Diabetes Telemedicine Mediterranean Diet (DiaTeleMed) Study: study protocol for a fully remote randomized clinical trial evaluating personalized dietary management in individuals with type 2 diabetes-Reference-Cited by-同舟云学术

Diabetes Telemedicine Mediterranean Diet (DiaTeleMed) Study: study protocol for a fully remote randomized clinical trial evaluating personalized dietary management in individuals with type 2 diabetes

Published:2024-07-25 Issue:1 Volume:25 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Berube Lauren T.^ORCID,Popp Collin J.,Curran Margaret,Hu Lu,Pompeii Mary Lou,Barua Souptik,Bernstein Emma,Salcedo Vanessa,Li Huilin,St-Jules David E.,Segal Eran,Bergman Michael,Williams Natasha J.,Sevick Mary Ann

Funder

National Institute of Nursing Research

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13063-024-08337-w.pdf

Reference45 articles.

1. Centers for Disease Control and Prevention. National diabetes statistics report. https://www.cdc.gov/diabetes/php/data-research/index.html. Accessed 22 Apr 2024.

2. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 3.Prevention or delay of type 2 diabetes and associated comorbidities: standards of care in diabetes—2023. Diabetes Care. 2022;46(Supplement_1):S41–8.

3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003;290(16):2159–67.

4. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.

5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–91.